Bobak Azamian

Bobak Azamian

Chief Executive Officer at TARSUS PHARMACEUTICALS, INC.

Net worth: 52 M $ as of 2026-05-30

48 year
Health Technology
Consumer Services
Finance

Profile

Bobak Azamian was the founder of Metavention, Inc., founded in 2012, where the title held was President & Chief Medical Officer in 2018.
Dr. Azamian is the founder of Tarsus Pharmaceuticals, Inc., founded in 2017, holding the titles of Chairman, President & Chief Executive Officer since 2022.
Dr. Azamian is the founder of Vibrato Medical, Inc., founded in 2016, serving as Director.
Dr. Azamian is also the founder of Novel Therapeutics Co...
Dr. Azamian currently serves as Director at Osanni Bio, Inc. since 2022.
Former positions include Director at OCTANe, Principal at Amgen, Inc., Principal at Versant Venture Management LLC, and Senior Associate at Third Rock Ventures LLC.
Education includes a doctorate from the University of Oxford, an undergraduate degree from William Marsh Rice University, and a doctorate from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-16 881,412 ( 2.05% ) 52 M $ 2026-05-30

Bobak Azamian active positions

CompaniesPositionStart
TARSUS PHARMACEUTICALS, INC. Chief Executive Officer 2018-08-31
Founder 2016-11-30

Former positions of Bobak Azamian

CompaniesPositionEnd
Chief Executive Officer 2017-12-31
Novel Therapeutics Co.
Founder -
Director/Board Member -
Private Equity Investor -
AMGEN INC. Corporate Officer/Principal -
See the detail of Bobak Azamian's experience

Training of Bobak Azamian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

7

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Novel Therapeutics Co.